Purdue Pharma, the company that makes OxyContin, launched a $23.8 million ad campaign this week to inform people harmed by their drug where they can file claims against the company, The Associated Press reports.
Prescriptions for benzodiazepines—used to relieve anxiety, agitation or sleep problems—are on the rise in the United States, according to a new study from the Centers for Disease Control and Prevention.
The drugs gabapentin and baclofen, both of which are sometimes prescribed instead of opioids for chronic pain, are increasingly being misused, according to a new report. The drugs are being used in a growing number of suicide attempts.
Johnson & Johnson announced it has reached a $20.4 million settlement with two Ohio counties ahead of a huge federal trial to determine responsibility for the opioid crisis, The Washington Post reports.
The proposed settlement with OxyContin maker Purdue Pharma is “no more than a stopgap for local and state governments,” which will continue to face costs related to the opioid crisis that far exceed the agreed upon amounts, according to a new report by Moody’s Investors Services.
OxyContin maker Purdue Pharma has reached a tentative settlement worth billions of dollars to resolve thousands of lawsuits brought by state and local governments who sued the drug company for its role in the opioid epidemic.
Opioid-related death rates between 2006 and 2012 were highest in rural communities in West Virginia, Kentucky and Virginia with a disproportionate share of opioid painkiller prescriptions, according to an analysis by The Washington Post.
On the second day of trial of a lawsuit against drug company Johnson & Johnson, the father of a college football player who died of an opioid overdose gave emotional testimony about the personal impact of the opioid crisis, Reuters reports.